Mymetics

Mymetics ROA

The Return on Assets (ROA) of Mymetics (MYMX) as of Oct 18, 2026 is -65.63 %. In the previous year, Return on Assets (ROA) was -61.98 % — a change of 5.90% (lower).

ROA

-65.63 %

YoY

5.90%

Last updated:

In 2022, Mymetics's return on assets (ROA) was -65.63 %, a 5.90% increase from the -61.98 % ROA in the previous year.

The Mymetics ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2015
-25.67 EUR
Jan 1, 2016
-71.51 EUR
Jan 1, 2017
-51.13 EUR
Jan 1, 2018
-53.43 EUR
Jan 1, 2019
-53.10 EUR
Jan 1, 2020
-51.36 EUR
Jan 1, 2021
-61.98 EUR
Jan 1, 2022
-65.63 EUR
The Mymetics ROA history
YEARROAYoY
-65.63 %+5.90%
-61.98 %+20.67%
-51.36 %-3.28%
-53.10 %-0.62%
-53.43 %+4.50%
-51.13 %-28.50%
-71.51 %+178.53%
-25.67 %-13.18%
-29.57 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Mymetics Stock analysis

What does Mymetics do? Mymetics Corp, listed under the ticker MYMX with ISIN US62856A3005, is a biotechnology company based in Epalinges, Switzerland. The company operates within the Health Care sector, specifically in the Biotechnology industry. Mymetics Corp has an employee count of 8 and went public on February 10, 1995. The company's website is https://www.mymetics.com/. Mymetics Corp focuses on the research and development of virosome-based vaccines for infectious diseases. Virosomes are lipid-based carriers that incorporate functional fusion viral proteins and natural membrane proteins, combined with rationally designed antigens. The company has multiple vaccine candidates in its pipeline, including those targeting HIV-1/AIDS, influenza, malaria, herpes simplex virus (HSV), and respiratory syncytial virus (RSV). The HIV-1 vaccine candidate utilizes virosomes linked to conserved antigens derived from HIV-1 glycoprotein 41 (gp41) proteins of clade B. The RSV vaccine candidate is composed of reconstituted RSV membrane containing native viral proteins. Similarly, the HSV vaccine candidate consists of reconstituted membranes from HSV-1 or HSV-2, while the intranasal influenza vaccine includes reconstituted influenza virus membranes. Mymetics Corp's technology aims to develop prophylactic vaccines through these virosome-based approaches. The company's headquarters are located in Epalinges, Vaud, Switzerland. The firm's current focus is on advancing its pipeline of vaccine candidates for various infectious diseases through innovative virosome technology. Mymetics is one of the most popular companies on Eulerpool.

ROA Details

Understanding Mymetics's Return on Assets (ROA)

Mymetics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Mymetics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Mymetics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Mymetics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Mymetics stock

Return on Assets (ROA) of Mymetics is -65.63 % in 2022.

Return on Assets (ROA) of Mymetics changed from -61.98 % to -65.63 %, representing a 5.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Mymetics since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Mymetics with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Mymetics

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Mymetics